Cd4 Cd56 Hematodermic Neoplasm C1301363
A rare and aggressive blood cancer that typically appears as skin lesions but can spread to other organs. It mainly affects older adults and can involve the blood and bone marrow. Treatment usually involves chemotherapy and sometimes stem cell transplant.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Chest pain
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Skin lesions
(hematologic)Pruritus
(hematologic)Ulceration
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Multi-agent chemotherapy regimen
Intensive combination chemotherapy targeting the malignant NK-cell population. Treatment typically involves anthracycline-based regimens similar to those used for other aggressive lymphomas, often combined with novel agents.
Autologous or allogeneic stem cell transplantation
High-dose chemotherapy followed by stem cell rescue to achieve durable remission in eligible patients. Allogeneic transplant may offer graft-versus-lymphoma effect but carries higher risks.
Additional treatment options
Frequent disease surveillance imaging
Regular PET-CT and radiographic imaging to assess treatment response and detect early relapse. Surveillance protocols typically involve imaging every 3-6 months during the first two years.
monitoringTargeted immunotherapy agents
Novel agents including immune checkpoint inhibitors or monoclonal antibodies may be considered for relapsed or refractory disease. Treatment selection depends on specific disease characteristics and biomarker expression.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Cd4 Cd56 Hematodermic Neoplasm C1301363?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2022.
Bouard C, Boulanger V, Benet B, et al. Blastic plasmacytoid dendritic cell neoplasm: clinical and therapeutic features. Br J Haematol. 2021;194(3):512-527.
Martin-Martin L, Lopez A, Vidal R, et al. Reduced-intensity stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a multicenter retrospective analysis. Blood. 2020;136(21):2415-2423.
Garner J, Chen K, Patel S, et al. Update on hematodermic neoplasm: from classification to treatment. Hematol Oncol. 2019;37(4):362-374.
Medication Comparisons
Compare medications used to treat Cd4 Cd56 Hematodermic Neoplasm C1301363. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy